BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 27435935)

  • 1. Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy.
    Nagata H; Nakagawa M; Nishimura-Sakurai Y; Asano Y; Tsunoda T; Miyoshi M; Kaneko S; Goto F; Otani S; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Azuma S; Kakinuma S; Tojo N; Tohda S; Asahina Y; Watanabe M;
    Hepatol Int; 2016 Nov; 10(6):956-964. PubMed ID: 27435935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.
    Sasaki R; Yamasaki K; Abiru S; Komori A; Nagaoka S; Saeki A; Hashimoto S; Bekki S; Kugiyama Y; Kuno A; Korenaga M; Togayachi A; Ocho M; Mizokami M; Narimatsu H; Ichikawa T; Nakao K; Yatsuhashi H
    PLoS One; 2015; 10(6):e0129053. PubMed ID: 26070204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C.
    Ura K; Furusyo N; Ogawa E; Hayashi T; Mukae H; Shimizu M; Toyoda K; Murata M; Hayashi J
    Aliment Pharmacol Ther; 2016 Jan; 43(1):114-24. PubMed ID: 26503582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein.
    Sato S; Genda T; Ichida T; Amano N; Sato S; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Hirano K; Shimada Y; Iijima K; Wada R; Nagahara A; Watanabe S
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA
    Inoue T; Tsuzuki Y; Iio E; Shinkai N; Matsunami K; Fujiwara K; Matsuura K; Nojiri S; Tanaka Y
    Jpn J Infect Dis; 2018 May; 71(3):177-183. PubMed ID: 29491234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C.
    Nagata H; Nakagawa M; Asahina Y; Sato A; Asano Y; Tsunoda T; Miyoshi M; Kaneko S; Otani S; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Azuma S; Kakinuma S; Nouchi T; Sakai H; Tomita M; Watanabe M;
    J Hepatol; 2017 Nov; 67(5):933-939. PubMed ID: 28627363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B.
    Kawaguchi K; Honda M; Ohta H; Terashima T; Shimakami T; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Komura T; Unoura M; Kaneko S
    J Gastroenterol; 2018 Jun; 53(6):740-751. PubMed ID: 28849280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
    Fujiyoshi M; Kuno A; Gotoh M; Fukai M; Yokoo H; Kamachi H; Kamiyama T; Korenaga M; Mizokami M; Narimatsu H; Taketomi A;
    J Gastroenterol; 2015 Nov; 50(11):1134-44. PubMed ID: 25773774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C.
    Takemura K; Takizawa E; Tamori A; Nakamae M; Kubota H; Uchida-Kobayashi S; Enomoto M; Kawada N; Hino M
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.
    Kim SU; Heo JY; Kim BK; Park JY; Kim DY; Han KH; Ahn SH; Kim HS
    Liver Int; 2017 Jun; 37(6):879-887. PubMed ID: 27973711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study.
    Okada A; Kanzaki H; Hamatani Y; Takashio S; Takahama H; Amaki M; Hasegawa T; Sugano Y; Yasuda S; Anzai T
    Heart Vessels; 2018 Apr; 33(4):385-392. PubMed ID: 29098408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
    Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
    World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapy.
    Liu T; Sun Y; Zhou J; Yang F; Zou X; Wang L; Wu X; Chen Y; Piao H; Lu L; Jiang W; Xu Y; Feng B; Nan Y; Xie W; Chen G; Zheng H; Li H; Ding H; Liu H; Wang T; Ou X; Wu S; Kong Y; Wang P; Cong M; Zhang Y; You H; Jia J
    J Med Virol; 2019 Aug; 91(8):1499-1509. PubMed ID: 30905065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.
    Yamasaki K; Tateyama M; Abiru S; Komori A; Nagaoka S; Saeki A; Hashimoto S; Sasaki R; Bekki S; Kugiyama Y; Miyazoe Y; Kuno A; Korenaga M; Togayachi A; Ocho M; Mizokami M; Narimatsu H; Yatsuhashi H
    Hepatology; 2014 Nov; 60(5):1563-70. PubMed ID: 25042054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not α-fetoprotein as a Long-Term Hepatocellular Carcinoma Predictor.
    Osawa L; Tamaki N; Kurosaki M; Kirino S; Watakabe K; Wang W; Okada M; Shimizu T; Higuchi M; Takaura K; Takada H; Kaneko S; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Enomoto N; Izumi N
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis.
    Kono M; Nakamura Y; Oyama Y; Mori K; Hozumi H; Karayama M; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Yamada M; Hamada E; Colby TV; Maekawa M; Suda T
    Respir Med; 2016 Jun; 115():46-52. PubMed ID: 27215503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels and liver fibrosis: A meta-analysis.
    Ito K; Murotani K; Nakade Y; Inoue T; Nakao H; Sumida Y; Kamada Y; Yoneda M
    J Gastroenterol Hepatol; 2017 Dec; 32(12):1922-1930. PubMed ID: 28406534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment.
    Cheung KS; Seto WK; Wong DK; Mak LY; Lai CL; Yuen MF
    Oncotarget; 2017 Jul; 8(29):47507-47517. PubMed ID: 28537900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.
    Heo JY; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Park YN; Ahn SS; Han KH; Kim HS
    Medicine (Baltimore); 2016 Apr; 95(14):e3328. PubMed ID: 27057911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.
    Hasegawa K; Takata R; Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Yuri Y; Nakano C; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.